Coordinating Longevity Care in Chicago: Questions About Location and Telehealth
For Chicago-area patients, the practical questions are where an assessment takes place, how records are shared with existing clinicians, and whether telehealth is appropriate where the patient is located.
By BluePath Longevity Editorial Team
Medical review pending — Dr. Syeda Madani, DO. Physician background and credentials.
For people in Chicago and nearby communities considering longevity-focused care, start by confirming where the clinician practices, which parts of an assessment require an in-person visit, and how the plan will coordinate with your primary care and specialty clinicians. BluePath Longevity lists its office at 1111 Plaza Drive, Suite 640, Schaumburg, Illinois. That is a suburban office, not a downtown Chicago location; confirm travel and appointment details with the practice before scheduling.
Ask what can be handled remotely
A video visit may be convenient for a history, discussion of goals, or review of available results, but telehealth is not automatically suitable for every clinical question. Some evaluations may require an in-person examination, measurement, specimen collection, or diagnostic procedure. Ask in advance which steps can be virtual, which require a visit to the Schaumburg office or another specified location, and how results and next steps will be delivered.
Telehealth availability also depends on the patient’s location and the clinician’s authority to practice there. Illinois law provides that a health professional treating a patient located in Illinois through telehealth must be licensed or authorized to practice in Illinois. [1] People traveling or living outside Illinois should ask the practice whether a visit is legally and clinically available in their location rather than assume that an Illinois appointment can be conducted across state lines.
Keep your existing care team in the picture
A longevity consultation is not a replacement for routine primary care, established specialists, or urgent services. Before an appointment, consider bringing or arranging secure transfer of relevant records, medication and supplement lists, previous test results, and your primary care clinician’s contact details. Agree on who will communicate abnormal results and who will follow up on recommendations. With your permission, sharing a concise assessment summary can help prevent duplicate testing and conflicting plans.
Ask whether a proposed test could change your care and whether it is appropriate for your circumstances. Preventive testing should be selected rather than ordered as a blanket package: screening recommendations account for evidence and may vary with age and risk, while screening can also lead to false positives and unnecessary follow-up. [2] A longevity-focused biomarker score is not, by itself, proof that a treatment extends life or prevents disease; surrogate measures require evidence that they predict meaningful clinical benefits. [3]
Plan for access and practical logistics
The listed Schaumburg address may help people compare travel time, work schedules, and whether an in-person visit is feasible. Ask the practice to confirm the current location, parking or arrival instructions, appointment format, what records to provide, and any separate testing arrangements. For a neutral overview of available services, see the site’s assessment list, cardiometabolic assessment, and executive longevity program pages. For general questions about roles and selection, read how longevity care works with primary care, what a healthy-aging assessment involves, and how to evaluate a longevity doctor. For the practice’s stated background and service context, see the existing Chicago physician guide and Dr. Madani’s biography.
Telehealth and scheduled preventive consultations are not emergency care. If you or someone nearby has possible heart-attack symptoms or sudden stroke symptoms, call 911 immediately; do not wait for a virtual visit or drive yourself to the hospital. [4][5]
Sources
- Illinois General Assembly, 225 ILCS 150/10, “Practice authority.”
- U.S. Preventive Services Task Force, “Individualizing Cancer Screening in Older Adults.”
- U.S. Food and Drug Administration, “Surrogate Endpoint Resources for Drug and Biologic Development.”
- Centers for Disease Control and Prevention, “Signs and Symptoms of Stroke.”
- Centers for Disease Control and Prevention, “About Heart Attack Symptoms, Risk, and Recovery.”
Educational information only, not a diagnosis or an individualized treatment recommendation. Keep appropriate primary and specialist care; discuss testing and treatment with your clinician.